Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -308.05% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -41.51% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -139.86% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 129.18% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.71% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -366.90% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -96.43% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -773.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -773.89% |
| Mar 31, 2026 | 95.02% |
| Dec 31, 2025 | -11,363.83% |
| Sep 30, 2025 | -464.29% |
| Jun 30, 2025 | 710.77% |
| Mar 31, 2025 | -2,010.79% |
| Dec 31, 2024 | -110.29% |
| Sep 30, 2024 | 299.47% |
| Jun 30, 2024 | 51.65% |
| Mar 31, 2024 | 66.65% |
| Dec 31, 2023 | 140.68% |
| Sep 30, 2023 | -113.96% |
| Jun 30, 2023 | 43.91% |
| Mar 31, 2023 | 98.71% |
| Dec 31, 2022 | -2,291.39% |
| Sep 30, 2022 | 728.95% |
| Jun 30, 2022 | -255.76% |
| Mar 31, 2022 | -4,153.90% |
| Dec 31, 2021 | 91.52% |
| Sep 30, 2021 | 83.81% |